Pemetrexed

Vladimir Beljanski

doi:10.1016/B978-008055232-3.63731-6

Pemetrexed

Vladimir Beljanski

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Original language	English
Title of host publication	xPharm
Subtitle of host publication	The Comprehensive Pharmacology Reference
Editors	S.J. Enna, David B. Bylund
Publisher	Elsevier Inc.
Pages	1-5
Number of pages	5
ISBN (Print)	9780080552323
DOIs	https://doi.org/10.1016/B978-008055232-3.63731-6
State	Published - 2007
Externally published	Yes

ASJC Scopus Subject Areas

General Pharmacology, Toxicology and Pharmaceutics

Disciplines

Medicine and Health Sciences

Access to Document

10.1016/B978-008055232-3.63731-6

Cite this

@inbook{1e9f4dc002904bf68a2a1f35050dae4e,

title = "Pemetrexed",

abstract = "Pemetrexed is an antineoplastic agent that disrupts folate-dependent metabolic processes. In vitro studies have shown that pemetrexed inhibits folate-dependent enzymes such as. {\textcopyright} 2007",

author = "Vladimir Beljanski",

year = "2007",

doi = "10.1016/B978-008055232-3.63731-6",

language = "English",

isbn = "9780080552323",

pages = "1--5",

editor = "S.J. Enna and Bylund, \{David B.\}",

booktitle = "xPharm",

publisher = "Elsevier Inc.",

address = "United States",

}

TY - CHAP

T1 - Pemetrexed

AU - Beljanski, Vladimir

PY - 2007

Y1 - 2007

UR - https://www.scopus.com/pages/publications/84884008157

UR - https://www.scopus.com/pages/publications/84884008157#tab=citedBy

U2 - 10.1016/B978-008055232-3.63731-6

DO - 10.1016/B978-008055232-3.63731-6

M3 - Chapter

AN - SCOPUS:84884008157

SN - 9780080552323

SP - 1

EP - 5

BT - xPharm

A2 - Enna, S.J.

A2 - Bylund, David B.

PB - Elsevier Inc.

ER -

Pemetrexed

Abstract

ASJC Scopus Subject Areas

Disciplines

Access to Document

Other files and links

Fingerprint

Cite this